Go Pro
OTCMKTS:CZMWY

Carl Zeiss Meditec (CZMWY) Stock Price, News & Analysis

Carl Zeiss Meditec logo
$34.50 +0.86 (+2.54%)
As of 11:21 AM Eastern

About Carl Zeiss Meditec Stock (OTCMKTS:CZMWY)

Advanced

Key Stats

Today's Range
$34.50
$34.75
50-Day Range
$28.41
$36.47
52-Week Range
$26.65
$55.94
Volume
341 shs
Average Volume
4,492 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery. In the Ophthalmic Devices segment, Carl Zeiss Meditec develops and markets diagnostic instruments such as optical coherence tomography (OCT) systems, fundus cameras and tonometers, as well as therapeutic laser platforms for refractive surgery and cataract treatment. Within Microsurgery, the firm produces high-precision surgical microscopes and handheld visualization tools that serve specialties including neurosurgery, ear-nose-throat (ENT) and dentistry. Each product line is designed to deliver enhanced image quality, ergonomic operation and reliable performance in clinical environments.

Operating across Europe, the Americas, Asia-Pacific and select emerging markets, Carl Zeiss Meditec maintains a broad international sales and service network. The company collaborates closely with hospitals, clinics and research institutions to support clinical training and product development. Its global footprint is supported by regional offices, production sites and service centers, ensuring timely access to technical support and spare parts.

Governed by a management board of experienced executives in optics, medical technology and healthcare, Carl Zeiss Meditec continues to emphasize research and development. The company reinvests a significant portion of its revenues into new technologies, with the aim of advancing patient outcomes and increasing surgical precision. Through ongoing innovation and strong aftermarket support, Carl Zeiss Meditec remains a key partner for healthcare professionals worldwide.

AI Generated. May Contain Errors.

Receive CZMWY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CZMWY Stock News Headlines

CZMWY Share News Today
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
Carl Zeiss Meditec: Bad Optics But With 'Buy' Potential
Carl Zeiss Meditec: Hitting The Bottom
See More Headlines

CZMWY Stock Analysis - Frequently Asked Questions

Carl Zeiss Meditec's stock was trading at $46.8470 on January 1st, 2026. Since then, CZMWY stock has decreased by 26.4% and is now trading at $34.4960.

Shares of CZMWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/07/2026
Fiscal Year End
9/30/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:CZMWY
CIK
N/A
Fax
N/A
Employees
4,823
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (OTCMKTS:CZMWY) was last updated on 8/7/2026 by MarketBeat.com Staff.
From Our Partners